Corcept Therapeutics Incorporated

NASDAQ:CORT

59.6 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income 106.14101.418112.512106.01194.18175.41129.1228.14-6.408-31.383-46.011-38.048-32.354-25.966-20.166-20.061-11.573-24.873-20.093-15.534-9.812
Depreciation & Amortization 2.3622.9693.0672.2372.1710.2360.1060.0870.1550.1410.0740.0270.0030.0060.010.0120.0130.0140.7041.610.023
Deferred Income Tax -29.493-33.9054.34614.08916.87714.067-76.703000000000-1.060-0.697-1,609.3820
Stock Based Compensation 48.9442.44242.93133.53929.31323.74713.3617.0586.0135.2015.1965.313.4352.1161.7991.6241.0600.6971,609.3820
Change In Working Capital 8.2186.016-0.057-5.357-4.6873.926-5.7141.1560.5-5.042-0.762-5.0061.5161.5590.373-1.222-0.4640.0682.0850.128-0.477
Accounts Receivables -10.066-3.432-1.427-6.27-2.34-2.288-5.44-3.639-2.887-1.906-0.871-0.557000000000
Inventory 1.2651.1993.444-3.514-1.044-7.779-2.262-0.6820.8150.249-0.883-4.663000000000
Accounts Payables 5.7784.757-3.5973.161-0.735-0.3896.2890.965-0.561-0.495-1.4230.1932.794-0.453-0.0340.1890.1990-0.001227.710
Other Working Capital 11.2413.4921.5231.266-0.56814.382-4.3014.5123.133-2.892.4150.021-1.2782.0120.407-1.411-0.6630.0682.086-227.582-0.477
Other Non Cash Items -9.1281.3835.0931.451-1.738-1.7210.7631.952.873.7074.4451.697000.0161.2851.061.5530.070.0780.264
Operating Cash Flow 127.039120.323167.892151.97136.117115.66560.93518.3913.13-27.376-37.058-36.02-27.4-22.285-17.968-18.362-10.964-23.238-17.234-13.718-10.003
Investing Activities:
Investments In Property Plant And Equipment -0.139-0.413-0.469-1.238-1.088-0.298-0.419-0.194-0.017-0.174-0.127-0.151-0.0250-0.007-0.0070-1.315-25.863-103.8980
Acquisitions Net -91.045113.914-136.595118.025116.74000000000000025.92200
Purchases Of Investments -328.748-355.066-312.805-420.114-299.035-233.124-73.0370000000-3.594-3.594-6.380-25.863-103,898.273-11.668
Sales Maturities Of Investments 419.793241.152449.4302.089182.295142.655000000003.5945.93126.67640.97164.38513.305
Other Investing Activites 91.045-113.914136.595-118.025-116.74-90.469-73.03700000003.601000-0.059103,898.2730
Investing Cash Flow 90.906-114.327136.126-119.263-117.828-90.767-73.456-0.194-0.017-0.174-0.127-0.151-0.02503.5942.329-5.3825.36115.108-39.5131.637
Financing Activities:
Debt Repayment 0-2.199-2.025-1.685-1.4520-15.134-14.779-9.207-4.856-1.02500-0.006-0.01-0.01300000
Common Stock Issued 5.8114.38116.22923.2268.4199.3227.1817.68322.28100.05559.70842.48223.00223.53519.32318.8662.9360.00149.0260
Common Stock Repurchased -145.428-21.665-295.985-9.945-30.975-23.657000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities -9.10626.063-6.60622.1592.339.3227.1817.68322.2811.777-1.02529.86-0.006-0.006-0.0130.0060.0050.0310.0110.0620.037
Financing Cash Flow -148.723-17.284-302.59112.214-28.645-14.335-7.953-7.09613.074-3.079-0.9789.56842.48222.99623.52519.31618.8712.9670.01249.0880.038
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000
Net Change In Cash 69.222-11.2881.42744.921-10.35610.563-20.47411.10116.187-30.629-38.15553.39715.0570.7119.1513.2832.5275.09-2.114-4.143-8.328
Cash At End Of Period 135.55166.32977.61776.1931.26941.62531.06251.53640.43524.24854.87793.03239.63524.57823.86714.71611.4338.9063.8165.9310.073